SCHEMBL27627179

SCHEMBL27627179

NC1CC(NC=O)N(NC=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28862004 0.77 — —
SCHEMBL27693621 0.64 ADH1B (0.38) —
SCHEMBL27647412 0.63 ADH1B (0.30) —
SCHEMBL28233826 0.61 — —
SCHEMBL28310282 0.60 — —
SCHEMBL28161986 0.60 — —
SCHEMBL7329448 0.58 — —
SCHEMBL16437032 0.56 — —
Hydrochloric Acid SCHEMBL28519717 0.54 GNAI3 (0.31) —
SCHEMBL28148093 0.54 ADH1B (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101102818-A Medicaments comprising carbonyl compounds, and the use thereof MERCK PATENT GMBH (DE) 2008-01-09 — — CN disclosed
CN-1771237-A 1- (phenylcarbamoyl) -2- (4- (3-oxo-morpholin-4-yl) -phenylcarbamoyl) pyrrolidine derivatives and related compounds as inhibitors of coagulation factor X A in the treatment of thromboembolic disorders MERCK PATENT GMBH (DE) 2006-05-10 — — CN disclosed
Send feedback